These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 38360626

  • 1. Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials.
    Lyu YS, Hong S, Lee SE, Cho BY, Park CY.
    Cardiovasc Diabetol; 2024 Feb 15; 23(1):71. PubMed ID: 38360626
    [Abstract] [Full Text] [Related]

  • 2. Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
    Asgharzadeh A, Patel M, Connock M, Damery S, Ghosh I, Jordan M, Freeman K, Brown A, Court R, Baldwin S, Ogunlayi F, Stinton C, Cummins E, Al-Khudairy L.
    Health Technol Assess; 2024 Dec 15; 28(80):1-190. PubMed ID: 39673446
    [Abstract] [Full Text] [Related]

  • 3. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA, Raz I, Mosenzon O, Dwyer JP, Heerspink HHJL, Cahn A, Goodrich EL, Im K, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Gause-Nilsson I, Langkilde AM, Sabatine MS, Wiviott SD.
    JAMA Cardiol; 2021 Jul 01; 6(7):801-810. PubMed ID: 33851953
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study.
    Hong JH, Kim MJ, Min KW, Won JC, Kim TN, Lee BW, Kang JG, Kim JH, Park JH, Ku BJ, Lee CB, Kim SY, Shon HS, Lee WJ, Park JY.
    Diabetes Obes Metab; 2025 Jan 01; 27(1):81-91. PubMed ID: 39375869
    [Abstract] [Full Text] [Related]

  • 5. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
    Handelsman Y.
    Adv Ther; 2019 Oct 01; 36(10):2567-2586. PubMed ID: 31444707
    [Abstract] [Full Text] [Related]

  • 6. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH.
    Cochrane Database Syst Rev; 2015 Oct 26; 2015(10):CD007698. PubMed ID: 26497719
    [Abstract] [Full Text] [Related]

  • 7. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF.
    Health Technol Assess; 2022 Oct 26; 26(44):1-310. PubMed ID: 36321689
    [Abstract] [Full Text] [Related]

  • 8. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
    Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P.
    CNS Drugs; 2010 Dec 26; 24(12):1041-54. PubMed ID: 21090838
    [Abstract] [Full Text] [Related]

  • 9. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J, Gaudet LA, Saba S, Vandermeer B, Ashiq AR, Wingert A, Hartling L.
    Syst Rev; 2024 Nov 26; 13(1):289. PubMed ID: 39593159
    [Abstract] [Full Text] [Related]

  • 10. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial.
    Kim P, Sanchez AM, Penke TJR, Tuson HH, Kime JC, McKee RW, Slone WL, Conley NR, McMillan LJ, Prybol CJ, Garofolo PM.
    Lancet Infect Dis; 2024 Dec 26; 24(12):1319-1332. PubMed ID: 39134085
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH.
    Clin Orthop Relat Res; 2024 Dec 01; 482(12):2193-2208. PubMed ID: 39051924
    [Abstract] [Full Text] [Related]

  • 12. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
    Sake JK, Hebert D, Isojärvi J, Doty P, De Backer M, Davies K, Eggert-Formella A, Zackheim J.
    CNS Drugs; 2010 Dec 01; 24(12):1055-68. PubMed ID: 21090839
    [Abstract] [Full Text] [Related]

  • 13. The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
    Elbarbary NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, Elkholy AA.
    Diabetologia; 2024 Dec 01; 67(12):2637-2649. PubMed ID: 39271520
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials.
    Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE.
    J Bone Miner Res; 2005 Dec 01; 20(12):2105-15. PubMed ID: 16294264
    [Abstract] [Full Text] [Related]

  • 15. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY, Schneider L, Loy C.
    Cochrane Database Syst Rev; 2024 Nov 05; 11(11):CD001747. PubMed ID: 39498781
    [Abstract] [Full Text] [Related]

  • 16. Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.
    Jabbour S, Seufert J, Scheen A, Bailey CJ, Karup C, Langkilde AM.
    Diabetes Obes Metab; 2018 Mar 05; 20(3):620-628. PubMed ID: 28950419
    [Abstract] [Full Text] [Related]

  • 17. Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients.
    Maung Myint T, Chong CH, von Huben A, Attia J, Webster AC, Blosser CD, Craig JC, Teixeira-Pinto A, Wong G.
    Cochrane Database Syst Rev; 2024 Nov 28; 11(11):CD014839. PubMed ID: 39606952
    [Abstract] [Full Text] [Related]

  • 18.
    Smith KC, Choi Y, Blackford AL, DeSanto J, Mayonado N, Rall S, White S, Bowie J, Hannum S, Johnston F, Joyner RL, Mischtschuk J, Peairs KS, Thorner E, Tran PT, Wolff AC, Snyder CF, Simplifying Survivorship Care Planning Stakeholder Advisory Board.
    ; 2022 05 28. PubMed ID: 39666842
    [Abstract] [Full Text] [Related]

  • 19. Platelet-rich therapies for musculoskeletal soft tissue injuries.
    Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC.
    Cochrane Database Syst Rev; 2014 Apr 29; 2014(4):CD010071. PubMed ID: 24782334
    [Abstract] [Full Text] [Related]

  • 20. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE.
    Health Technol Assess; 2021 Dec 29; 25(75):1-134. PubMed ID: 34931602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.